Showing results (141-150 of 330) with videos related to
Sort By:
Pageof 33
Annals of Surgical Oncology|February 25, 2011
DNA repair gene and MTHFR gene polymorphisms as prognostic markers in locally advanced adenocarcinoma of the esophagus or stomach treated with cisplatin and 5-fluorouracil-based neoadjuvant chemotherapyKatja Ott, P Sivaramakrishna Rachakonda, Benjamin Panzram, et al.Molecular Imaging and Biology|May 8, 2010
Association of the VEGF 936C>T polymorphism with FDG uptake, clinical, histopathological, and metabolic response in patients with adenocarcinomas of the esophagogastric junctionSylvie Lorenzen, Ben Panzram, Gisela Keller, et al.European Journal of Cancer (Oxford, England : 1990)|December 23, 2017
Histopathological regression predicts treatment outcome in locally advanced esophagogastric adenocarcinomaSilvia Spoerl, Alexander Novotny, Salah-Eddin Al-Batran, et al.Clinical and Experimental Medicine|June 4, 2025
Personalized drug stratification using endoscopic samples to assess ex vivo gastric cancer tissue susceptibility to chemotherapy and immune checkpoint inhibitorsLaura Hennig, Astrid Monecke, Ngoc Anh Hoang, et al.Journal of Cachexia, Sarcopenia and Muscle|August 30, 2019
Prognostic role of body composition parameters in gastric/gastroesophageal junction cancer patients from the EXPAND trialUlrich T Hacker, Dirk Hasenclever, Nicolas Linder, et al.Tumori|August 31, 2019
Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in patients with peritoneal metastasized colorectal, appendiceal and small bowel cancerInes Gockel, Boris Jansen-Winkeln, Linda Haase, et al.The Annals of Thoracic Surgery|June 27, 2006
Erythropoietin-alfa during neoadjuvant chemotherapy for locally advanced esophagogastric adenocarcinomaKathrin Abbrederis, Florian Bassermann, Christoph Schuhmacher, et al.Nature Reviews. Clinical Oncology|May 15, 2026
Transforming perioperative treatment of gastro-oesophageal adenocarcinoma: triumphs, setbacks and future horizonsHongcheng Zhu, Florian Lordick, Yelena Y Janjigian, et al.Onkologie|September 13, 2008
Complete remission in a colon cancer patient with a large, irresectable liver metastasis after XELOX/cetuximab/bevacizumab treatmentMartin R Weihrauch, Dirk Stippel, Jochen W U Fries, et al.Frontiers in Oncology|May 24, 2021
Standardized Diagnostics Including PET-CT Imaging, Bilateral Tonsillectomy and Neck Dissection Followed by Risk-Adapted Post-Operative Treatment Favoring Radio-Chemotherapy Improve Survival of Neck Squamous Cell Carcinoma of Unknown Primary PatientsGunnar Wichmann, Maria Willner, Thomas Kuhnt, et al.Pageof 33